Latigo Biotherapeutics
As seen on the 24/7 Wall St. homepage on July 17, 2026.
Latigo Biotherapeutics
LTGO · Nasdaq
Pain relief biotech Latigo filed to go public as non-opioid painkillers become the race to watch on Wall Street, backed by Goldman Sachs and Jefferies.
Mentioned: LTGO